Immune Responses After 2 Versus 3 Doses of HPV Vaccination up to 4½ Years After Vaccination: An Observational Study Among Dutch Routinely Vaccinated Girls.

Donken, RobineSchurink-Van't Klooster, Tessa MSchepp, Rutger Mvan der Klis, Fiona R MKnol, Mirjam JMeijer, Chris J L Mde Melker, Hester E2018-02-062018-02-062017-02-01Immune Responses After 2 Versus 3 Doses of HPV Vaccination up to 4½ Years After Vaccination: An Observational Study Among Dutch Routinely Vaccinated Girls. 2017, 215 (3):359-367 J. Infect. Dis.1537-66132801191610.1093/infdis/jiw588http://hdl.handle.net/10029/621320In 2014 the Netherlands switched from 3 to 2 doses for routine vaccination with the prophylactic bivalent human papillomavirus (HPV) vaccine. The current study explored whether antibody responses are noninferior after 2 versus 3 doses in girls.enArchived with thanks to The Journal of infectious diseasesAdolescentAntibodies, ViralAntibody AffinityChildDose-Response Relationship, ImmunologicFemaleHumansImmunogenicity, VaccinePapillomavirus InfectionsPapillomavirus VaccinesSingle-Blind MethodImmune Responses After 2 Versus 3 Doses of HPV Vaccination up to 4½ Years After Vaccination: An Observational Study Among Dutch Routinely Vaccinated Girls.ArticleJ Infect Dis 2017; 215(3):359-67